Metropolitan Life Insurance Company (MetLife)’s T. Rowe Price TROW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,029
Closed -$1.1M 1950
2024
Q1
$1.1M Sell
9,029
-66
-0.7% -$7.37K 0.05% 314
2023
Q4
$979K Sell
9,095
-184
-2% -$18.3K 0.05% 325
2023
Q3
$973K Sell
9,279
-507
-5% -$57.1K 0.05% 299
2023
Q2
$1.1M Sell
9,786
-245
-2% -$26.8K 0.05% 305
2023
Q1
$1.13M Sell
10,031
-2,893
-22% -$331K 0.06% 300
2022
Q4
$1.41M Sell
12,924
-178
-1% -$20.1K 0.06% 290
2022
Q3
$1.38M Sell
13,102
-252
-2% -$30.1K 0.07% 278
2022
Q2
$1.52M Sell
13,354
-453
-3% -$57.6K 0.07% 274
2022
Q1
$2.09M Sell
13,807
-15,040
-52% -$2.32M 0.07% 246
2021
Q4
$5.67M Sell
28,847
-1,033
-3% -$210K 0.08% 201
2021
Q3
$5.88M Sell
29,880
-1,002
-3% -$211K 0.09% 183
2021
Q2
$6.11M Buy
30,882
+85
+0.3% +$15.9K 0.09% 184
2021
Q1
$5.28M Sell
30,797
-1,448
-4% -$237K 0.08% 192
2020
Q4
$4.88M Sell
32,245
-1,508
-4% -$216K 0.07% 203
2020
Q3
$4.33M Sell
33,753
-1,536
-4% -$203K 0.07% 213
2020
Q2
$4.36M Sell
35,289
-2,527
-7% -$288K 0.08% 205
2020
Q1
$3.69M Sell
37,816
-195
-0.5% -$23.9K 0.08% 217
2019
Q4
$4.63M Sell
38,011
-513
-1% -$60.6K 0.07% 227
2019
Q3
$4.4M Sell
38,524
-7,442
-16% -$828K 0.07% 233
2019
Q2
$5.04M Buy
45,966
+2,172
+5% +$228K 0.09% 209
2019
Q1
$4.38M Sell
43,794
-2,236
-5% -$216K 0.08% 211
2018
Q4
$4.25M Sell
46,030
-175
-0.4% -$17K 0.09% 195
2018
Q3
$5.04M Sell
46,205
-979
-2% -$113K 0.09% 198
2018
Q2
$5.48M Buy
47,184
+8,357
+22% +$972K 0.09% 194
2018
Q1
$4.19M Buy
38,827
+506
+1% +$56.4K 0.06% 248
2017
Q4
$4.02M Sell
38,321
-76,834
-67% -$7.49M 0.05% 263
2017
Q3
$10.4M Sell
115,155
-2,430
-2% -$201K 0.07% 264
2017
Q2
$8.73M Sell
117,585
-10,162
-8% -$727K 0.06% 299
2017
Q1
$8.71M Sell
127,747
-1,828
-1% -$130K 0.06% 307
2016
Q4
$9.75M Sell
129,575
-5,954
-4% -$422K 0.07% 263
2016
Q3
$9.01M Sell
135,529
-1,335
-1% -$93K 0.07% 276
2016
Q2
$9.99M Sell
136,864
-5,262
-4% -$392K 0.07% 252
2016
Q1
$10.4M Sell
142,126
-3,647
-3% -$253K 0.08% 235
2015
Q4
$10.4M Sell
145,773
-4,413
-3% -$324K 0.08% 240
2015
Q3
$10.4M Sell
150,186
-5,963
-4% -$442K 0.08% 240
2015
Q2
$12.1M Buy
156,149
+1,553
+1% +$125K 0.09% 227
2015
Q1
$12.5M Sell
154,596
-1,202
-0.8% -$99K 0.09% 228
2014
Q4
$13.4M Sell
155,798
-1,246
-0.8% -$102K 0.09% 221
2014
Q3
$12.3M Sell
157,044
-2,364
-1% -$190K 0.09% 230
2014
Q2
$13.5M Sell
159,408
-6,766
-4% -$552K 0.09% 221
2014
Q1
$13.7M Sell
166,174
-1,896
-1% -$154K 0.09% 218
2013
Q4
$14.1M Sell
168,070
-2,802
-2% -$219K 0.1% 205
2013
Q3
$12.3M Sell
170,872
-895
-0.5% -$66.3K 0.09% 218
2013
Q2
$12.6M Buy
+171,767
New +$12.8M 0.1% 203

Other funds holding TROW

Metropolitan Life Insurance Company (MetLife)'s TROW Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of T. Rowe Price (TROW) in Q2 2024, closing a stake of 9,029 shares — an estimated $1.1M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TROW in Q2 2013 and held it in 44 quarters. The position peaked at $14.1M in Q4 2013. 1,067 funds tracked by Wall St. Rank hold TROW as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining T. Rowe Price position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 9,029 T. Rowe Price shares in Q2 2024, an estimated $1.1M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in T. Rowe Price in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s T. Rowe Price position peaked at $14.1M in Q4 2013.
  • 1,067 funds tracked by Wall St. Rank held T. Rowe Price as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.